FIGS Stock Outlook 2026: The Scrubs Brand Moat and the Single-Category Growth Problem

The Core Tension in FIGS: A Real Brand Moat With a Growth Ceiling

FIGS forces investors to answer a deceptively simple question: can a company that built a brand where none existed keep growing after that first success is spent?

My read is this. FIGS did something genuinely hard — it created a real brand and durable replenishment loyalty in medical scrubs, one of the most boring, fragmented, brandless categories in retail. That moat is real. But the central risk here is not competition; it is the growth ceiling of premium single-category apparel. Once early penetration matures, the growth rate bends, and the moment it does, a growth multiple unwinds fast. You have to underwrite both truths at once.

Scrubs are a strange product. Nurses and physicians wear them for their entire shift. They have to survive sweat, constant laundering, twelve-hour days, and a lot of squatting and reaching. And for a long time this category had no brand. What you bought at the hospital supply store was anonymous. FIGS walked in with a different premise: workwear can have a brand people actually care about.

For investors, FIGS is interesting because it compresses the classic American consumer-brand arc — explosive early growth, then the hard second chapter — into a single, watchable case. Lululemon started in yoga wear. FIGS started in scrubs. The whole question is how the next chapter gets written.

👉 For how brand loyalty and repeat purchase power a consumer name in a different category, read our MNST Monster Beverage stock outlook.

---

How FIGS Built a Brand in a Brandless Category

Break the moat into layers.

The brand itself. The defining feature of scrubs was a brand vacuum. Healthcare workers wore this clothing every single day and had no brand to care about. FIGS filled that void with technical fabrics, better fit, color variety, and social-media-driven community marketing that turned “what I wear to work” into a form of self-expression. That is not a product advantage; it is a category-defining brand advantage.

Replenishment loyalty. Scrubs are consumables. They fade, stretch out, and wear down with heavy laundering. A satisfied nurse replaces worn sets with the same brand. Acquire a customer once, and you capture years of repeat purchases — a lifetime value that makes FIGS’s revenue more predictable than typical fashion apparel, which lives and dies on the next trend.

Occupational identity. Scrubs are a uniform. When a nurse wears FIGS on the floor, colleagues notice the brand, generating organic word-of-mouth. FIGS turned this into a brand asset through ambassador programs and community content. The clothing becomes a walking billboard inside the exact community it wants to reach.

D2C data and margin. By selling directly rather than through wholesale, FIGS keeps the middleman margin and accumulates customer data. That has supported gross margins unusually high for the scrubs category.

None of this is impregnable. The brand premium is sustained by continuous marketing spend. Cut marketing and new-customer inflow slows; keep spending and profitability gets squeezed. That tension is the central variable in FIGS’s results.

---

The Premium-Price Logic: Why a Nurse Pays Up for Scrubs

To understand the bull case you have to understand why the customer pays more.

A nurse’s scrubs are not the same as an office worker’s blazer. They are worn for the whole shift, endure sweat and constant washing, and have to move with someone who stands for hours and crouches constantly. Fabric stretch, breathability, pocket layout, and fit each change how a hard shift actually feels. That is where willingness to pay a premium for “comfortable clothes that work” comes from.

FIGS aimed precisely at that. It led with technical fabrics, offered real color and fit variety, and pushed a message of “clothing that makes your workday better.” The result was a meaningful premium over anonymous scrubs, combined with repeat purchase.

The logic rhymes with early Lululemon, which started from “clothes that are comfortable for yoga” and built premium pricing and loyalty from that functional edge. The FIGS bull case is essentially a bet that it can be the Lululemon of scrubs.

But there is a crucial difference. Lululemon’s target was effectively “anyone who spends on health and lifestyle” — nearly unbounded. FIGS’s core target is “healthcare workers” — narrower and far more definable. A narrow market penetrates quickly, but it also hits a growth ceiling quickly once that penetration is done.

---

Growth Lever One: International and Teams (B2B) Expansion

FIGS’s US individual-consumer market is maturing. Future growth rests on two axes.

International markets. There are nurses and physicians everywhere, and most non-US scrubs markets remain fragmented and brandless — the same setup FIGS exploited at home. If FIGS can transplant its proven brand playbook abroad, the runway lengthens materially. But international expansion carries logistics, local-marketing, and currency costs, and brand awareness has to be rebuilt market by market.

Teams (B2B). This is the lever worth watching most. Selling to individuals costs marketing dollars every time. When a hospital or large clinic adopts FIGS as its staff uniform, one relationship generates bulk, recurring orders. Teams lowers customer acquisition cost and improves revenue predictability. That structural improvement is why investors track Teams mix expansion so carefully.

Growth lever	Mechanism	Strength	Risk
International	Transplant brand to unproven markets	Large runway, fragmented rivals	Logistics, FX, no local brand awareness
Teams (B2B)	Hospital/clinic bulk adoption	Bulk recurring orders, lower CAC	Long sales cycles, pricing pressure
Non-scrubs categories	Footwear, lifestyle, outerwear	Higher revenue per customer	Unproven, brand-extension failure risk

Non-scrubs categories. FIGS is extending into footwear, lifestyle apparel, and outerwear — selling more to existing customers to lift average order value. Succeed, and FIGS graduates from “a scrubs company” to “a healthcare lifestyle brand.” But category extension is one of the harder games in retail, with far more failures than successes.

👉 For a diversified healthcare growth structure that smooths this kind of volatility, compare with our MET MetLife stock outlook on how scale and diversification stabilize a business through cycles.

---

Why Single-Category Premium Apparel Stalls

This is the most-missed risk in FIGS analysis. Premium single-category apparel traces a distinctive growth curve.

Early on it explodes. When a brand enters a category that had none, customers who never had an option pour in fast. Revenue surges and the market mistakes the surge for an infinite growth story.

But as penetration advances, the pool of remaining new customers shrinks. Once the early enthusiasts are absorbed, growth can only come from (1) existing customers repeating, (2) the remaining unpenetrated buyers converting, and (3) new categories and geographies. If those three engines are not as fast as the initial land grab, the growth rate decelerates sharply.

The problem is that a growth multiple is priced on continued high growth. The first credible sign of deceleration triggers rapid multiple compression, and the stock falls far more than the fundamentals alone would justify. That is the classic trap of premium consumer growth stocks, and FIGS already lived through a version of it — high initial expectations followed by a sharp derating once growth concerns surfaced.

On top of that, scrubs have a durable-goods character. When the economy is soft or personal finances are stretched, even healthcare workers can defer buying new scrubs. “What I have still works, I’ll skip this year” hits revenue directly. That discretionary sensitivity is what makes FIGS a consumer growth stock rather than a defensive healthcare name, despite its healthcare-worker customer base.

---

The Competitive Landscape: Legacy Makers, Low Cost, and Brand Comparables

Competition comes from three directions.

Competitor type	Representative names	Nature of threat
Legacy scrubs makers	Careismatic Brands (Cherokee lines), Barco	Distribution, price, hospital procurement ties
Low-cost mass retail	Amazon, Walmart private scrubs	Absorb price-sensitive customers
New D2C challengers	Copycat scrubs startups	Imitate the FIGS playbook
Brand comparables (not direct)	Lululemon, Uniqlo	Possible collision on category expansion

Legacy scrubs makers. Careismatic Brands owns long-established scrubs lines like Cherokee and is deeply rooted in hospital procurement channels. Its brand cachet may trail FIGS, but its distribution, pricing, and institutional relationships are formidable.

Low-cost mass retail. Amazon and Walmart sell cheap scrubs at scale. Price-first buyers and anyone unwilling to pay up for scrubs go there. It is a segment where the FIGS premium simply does not translate.

Brand comparables. Lululemon and Uniqlo are not direct rivals, but they are the crucial reference points — Lululemon as the case of successful single-category-to-lifestyle expansion, Uniqlo as the case of functional basics conquering the mass market. As FIGS pushes into non-scrubs, it could brush up against their far broader brand power.

On brand, FIGS still leads. But its success signaled to challengers that scrubs D2C is profitable. When the entry barrier is brand and marketing rather than patents, a well-capitalized challenger can always attempt a similar strategy.

---

Investment Risks: The Balanced View

Growth deceleration is the most direct risk. Once single-category penetration matures, the growth rate bends and the growth multiple unwinds. How much international, Teams, and non-scrubs expansion offsets that deceleration is the crux of the valuation.

Inventory and margin risk is apparel’s chronic ailment. Miss the demand forecast, inventory piles up, and it gets cleared through discounting that directly damages gross margin. When a premium brand starts leaning on markdowns, the brand equity itself erodes. The gross margin trend is the window into this risk.

Discretionary sensitivity. Healthcare workers are an economically defensive occupation, but their scrubs purchases are discretionary. Tight finances lead to deferred replacement of a durable good. In a downturn, that sensitivity pressures revenue.

Founder and governance risk. FIGS grew under its co-founders and adopted a dual-class structure. Founder vision is a brand strength, but minority shareholders have limited oversight over capital allocation, marketing spend levels, and category-expansion decisions.

FX risk. For non-US investors, FIGS is a dollar stock, so currency moves flow straight into returns. And FIGS itself faces a translation headwind on growing international revenue when the dollar is strong. Manage the business risk and the currency risk separately.

---

Three Practical Investor Scenarios

Scenario 1: FIGS as a Growth Satellite Position

FIGS fits the “high-risk, high-growth satellite” slot rather than a portfolio core. The brand moat is real, but the single-category ceiling risk is large.

My approach would cap the single-stock weight around 3-5%, sizing it against real evidence that international and Teams mix is expanding. When quarterly results show the growth levers working, hold or add; when deceleration is confirmed, trim. Using FIGS alone to cover consumer-sector exposure would be a mistake.

Scenario 2: US Tax and Cost-Basis Discipline

For US investors, FIGS is a non-dividend growth stock, so returns are entirely capital gains — and holding period matters. Shares held over a year qualify for long-term capital gains rates; shares sold inside a year are taxed as short-term at ordinary income rates. Given FIGS’s volatility, the temptation to trade in and out is real, but frequent short-term selling can convert paper gains into a heavier tax bill. Holding in a tax-advantaged account (IRA/Roth) removes the annual drag for investors who want to own it through the growth-proof-out period. Harvesting losses in a bad year to offset other gains is a legitimate tool given how sharply this name can draw down.

Scenario 3: Growth-Metric-Linked Monitoring

FIGS suits metric-linked monitoring better than mechanical dollar-cost averaging, because a growth valuation depends on continued growth and the stock reacts hard when metrics wobble.

Key monitoring points: if active-customer growth keeps decelerating, revisit the thesis; if international and Teams mix does not expand on plan, the bull case weakens; if gross margin trends down on discounting, that flags inventory and demand-forecast problems. Add into improving metrics, trim into deteriorating ones — that discipline tends to produce a better risk-adjusted outcome over a full cycle.

👉 For another way to frame growth-stock selection, see our XPEV stock outlook on judging an unproven growth story against execution risk.

---

FIGS vs. Peers: Where It Sits in a Portfolio

Company	Category	Demand elasticity	Primary moat	Growth stage
FIGS	Premium scrubs D2C	High (discretionary)	Brand + replenishment loyalty	Growth (deceleration risk)
CHWY (Chewy)	Pet consumables D2C	Moderate (autoship)	Refill subscription + convenience	Growth
Careismatic (private ref.)	Legacy scrubs	Moderate	Distribution + procurement ties	Mature
Lululemon (reference)	Premium lifestyle	High (discretionary)	Brand + category expansion	Mature growth

The comparison locates FIGS honestly. Its customers are healthcare workers, but its demand profile is consumer discretionary. Misclassify FIGS as a defensive healthcare holding and you can eat an unexpected loss in a downturn.

The most reasonable framing is “premium consumer growth stock, still proving the second chapter.” The brand is genuine; the international, Teams, and non-scrubs engines are not yet proven. Watching that proof-out while sizing accordingly is the practical way to own this name.

👉 For a very different high-conviction growth-versus-risk profile, compare our CRSP CRISPR Therapeutics stock outlook on binary, unproven upside.

---

Quarterly Monitoring: The Metrics That Matter

If you hold or track FIGS, knowing what to read first each quarter sharpens the judgment.

First: active customers and growth rate. The most direct read on brand penetration. Persistent deceleration in new-customer inflow signals you are approaching the single-category ceiling. The direction of this number decides the fate of the growth thesis.

Second: average order value (AOV) and repeat rate. Repeat rate shows the health of replenishment loyalty; AOV shows whether category expansion (footwear, lifestyle) is actually widening the wallet. Rising repeat rate plus rising AOV means more revenue per existing customer.

Third: international and Teams (B2B) mix. The window into whether both growth levers are actually working. Expansion here means new engines are offsetting US maturity; stagnation weakens the bull case.

Fourth: gross margin. The lifeline of a premium brand. Held margin means pricing power is intact; a downtrend warns that inventory gluts and discounting are eroding the premium.

Fifth: marketing spend efficiency. Brand growth is sustained by marketing. If spend rises without proportional customer growth, acquisition efficiency is falling, which foreshadows profitability pressure.

Read together, these five track the qualitative health of the moat and the growth levers, well beyond the headline revenue number.

---

Related Reading

• 👉 MNST Monster Beverage Stock Outlook 2026
• 👉 MET MetLife Stock Outlook 2026
• 👉 XPEV Stock Outlook 2026
• 👉 CRSP CRISPR Therapeutics Stock Outlook 2026
• 👉 AI Stocks Investment Guide 2026: Core Holdings and ETF Strategy

---

This article is for informational purposes only and does not constitute a recommendation to buy or sell any security. Investing in stocks involves risk, including possible loss of principal. All analysis reflects the author’s view as of the writing date; verify with current filings and consult a licensed financial professional before making investment decisions.